# Current State to Market-Wide Prototype Report

Audit date: 2026-10-03  
Accepted source baseline: `cae8a11329d6ce685a483b895c970b47ef66e7dc`  
Scope: read-only current-state verification and acceptance reporting. No ingestion, reconciliation, valuation, factor, signal, database, or UI process was rerun.

## Decision

UZQUANT already satisfies the mandate's definition of a **functioning market-wide Uzbekistan equity research prototype**. No production-code change is justified. The system is market-wide in coverage, not market-wide in valuation availability: all 73 verified current equities are represented, attempted, and visible, while only IPKY has an executable valuation because the other methods fail closed on explicit evidence blockers.

## Baseline and change control

- Local HEAD and `origin/main`: `cae8a11329d6ce685a483b895c970b47ef66e7dc`.
- Branch: `main`.
- Tracked drift: none before this report-only change.
- Pre-existing untracked files, including `AGENTS.md`, local evidence databases, imports, temporary files, and unrelated documents, were not modified or included.
- Changes after Terminal Alpha `e8b57e761c812ae929bc044875b6fe91a602ffd5`:
  - UNIVERSE / IDENTITY: `39ae511` reconciled the verified RSE universe and retained historical-only securities.
  - RESEARCH COVERAGE: `a60127f` expanded market-wide coverage assessment.
  - FINANCIALS / VALUATION / FACTORS: `3e6932c`, `35b0cef`, and `5f0fac8` exhausted existing evidence, closed general parser/metric gaps, and hardened explicit metadata gates.
  - TERMINAL/UI: `bd6a8e9` expanded the existing terminal to the verified current universe.
  - FINANCIAL METADATA: `cae8a11` audited ownership/perimeter evidence without forcing unsupported classifications.

## Current verified state

- Verified current public RSE instruments: 86 unique instruments: 51 common equities, 22 preferred equities, and 13 bonds; no other/unknown current instruments.
- Current equity universe: 73 securities across 52 issuers.
- Historical-only securities preserved outside the current screener: 7. No delisting status is inferred without evidence.
- Reconciliation: 69 matched, 4 legitimate RSE-only equities canonically added, 7 UZQUANT-only historical securities, and zero identifier, classification, or ambiguity conflicts.
- Coverage: 50 equities with market data; 16 with financial documents; 14 with normalized fundamentals; 40 with verified share evidence; 4 with verified rights evidence; 2 with ownership evidence; 7 with liquidity assessments.
- Valuation: 1 equity with an executable valuation, IPKY Residual Income; 72 are `VALUATION_INSUFFICIENT`. Every supported method attempt has an explicit rejection reason.
- Factors: 5 equities have at least four available factors.
- Research state: 69 `DATA_INSUFFICIENT`, 2 `LIQUIDITY_TRAP`, 1 `HOLD`, and 1 `REDUCE`.
- Market history: 837 raw observations across 74 unique dates, from 2024-09-27 through 2026-09-28. Backfill queue: 1,784 pending, 79 imported, 36 empty, and 1 source-blocked.
- Operations: 17 of 17 latest pipeline-health records are `HEALTHY`. The latest successful production cycle updated the full dependency chain without manual database edits. Earlier failures remain preserved in run history.

## Structural review

Canonical issuer/security identity, effective identifier evidence, class separation, current/historical universe separation, immutable financial lineage, valuation/factor/signal lineage, source-health propagation, blocker drill-down, backend/UI agreement, and clean-checkout reproducibility are solved for prototype scope. Public evidence coverage remains partial by design. Unknown reporting perimeter, unit, security rights, ownership, free float, historical depth, peer sets, and valuation assumptions remain explicit blockers rather than software defaults.

## Acceptance criteria

All 20 prototype acceptance criteria pass:

1. The current RSE instrument universe is evidenced with complete listing pagination and the verified listing/quotation union.
2. Equities and bonds are separated.
3. All 73 current equities exist canonically.
4. All 73 appear in the terminal.
5. All 73 have a research/coverage attempt and blocker state.
6. The legitimately executable IPKY valuation executes.
7. Rejected valuation methods expose exact reasons.
8. Legitimately supported factors are populated; unsupported factors remain unavailable.
9. Missing values remain missing and render as `n/a`.
10. Common and preferred securities remain separate.
11. Provenance is preserved.
12. Point-in-time records and immutable lineage are enforced.
13. Market freshness and no-trade observations are explicit.
14. Backend and UI agree for all 73 equities.
15. A normal production refresh has completed the full dependency chain.
16. Development tests pass: 234.
17. The exact committed SHA passes 234 tests in a clean checkout when connected read-only to the production evidence database.
18. Foreign-key violations: 0.
19. No gate, threshold, weight, or readiness rule was weakened.
20. No valuation, recommendation, signal, or portfolio position was forced.

## Final verdict

### WHAT STAGE IS UZQUANT ACTUALLY AT NOW?

UZQUANT is a functioning market-wide research prototype with complete current-equity representation, deterministic evidence-backed analysis attempts, explicit blockers, and a verified read-only research terminal. Its analytical depth remains uneven because authoritative public disclosures are uneven.

### IS UZQUANT A FUNCTIONING MARKET-WIDE RESEARCH PROTOTYPE?

**YES.**

Proven scope: all 73 verified current RSE equities across 52 issuers are canonical, visible, class-separated, research-attempted, and explainable through backend-derived coverage, lineage, factor, valuation, liquidity, confidence, risk-gate, and blocker records. This does not imply that every equity is valuation-ready or investment-eligible.

## Higher maturity remains separate

- PAPER_TRADING: accumulate a longer immutable prospective sample and evaluate drift, execution assumptions, and observed outcomes.
- LIMITED_CAPITAL: requires stronger historical/prospective validation, broader valuation-ready evidence, deeper liquidity/capacity evidence, and operational controls.
- PRODUCTION/LIVE: requires production deployment hardening, authentication/authorization, managed durable storage and backups, monitoring/alert delivery, disaster recovery, security review, and explicit brokerage/execution governance. Autonomous trading remains disabled.

